未登录

H

Hyung Ryong Moon

pusan national university

H指数:40

被引数:5,680

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

N-Phenylthiocarbamate analogs, Cu(II)-chelating tyrosinase inhibitors, show more potent anti-pigmenting activity in higher organisms

N-苯基硫代氨基甲酸酯类似物，Cu(II)-螯合酪氨酸酶抑制剂，在高等生物中显示出更强的抗色素沉着活性

Dyes and Pigments

IF4.2

2026-09-300

PRE

Non-chelating 2-(arylthio)acetophenone derivatives as broad-spectrum tyrosinase inhibitors: Synthesis, in silico profiling, in vitro, and in vivo antimelanogenic efficacy

非螯合2-(芳硫基)乙酰苯衍生物作为广谱酪氨酸酶抑制剂：合成、计算机辅助分析、体外及体内抗黑色素生成活性

Bioorganic Chemistry

IF4.7

2026-09-250

PRE

Tyrosinase Inhibitors With Enhanced Potency in Mammalian and Vertebrate Models, N-(2-Mercaptoethyl)benzamide Derivatives: Design, Synthesis, and Evaluation

酪氨酸酶抑制剂在哺乳动物和脊椎动物模型中具有增强的活性，<i>N</i>-(2-巯乙基)苯甲酰胺衍生物：设计、合成与评价

Chemical Biology & Drug Design

IF3.3

2026-09-090

OAAI

MHY5535, a novel PPARα antagonist, sensitizes ovarian cancer stem cells to chemotherapy by disrupting fatty acid oxidation-dependent mitochondrial metabolism

MHY5535，一种新型PPARα拮抗剂，通过破坏脂肪酸氧化依赖的线粒体代谢使卵巢癌干细胞对化疗更敏感

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2026-08-120

OAAI

MHY5456, an FXR Agonist, Ameliorates Hepatic Steatosis and Fibrosis in a Mouse Model of MASLD

MHY5456，一种FXR激动剂，可改善MASLD小鼠模型中的肝脂肪变性和纤维化

Biomolecules & Therapeutics

IF3.2

2026-05-011

PRE

MHY498 Nanosuspensions for Improved Topical Drug Delivery: Understanding of Its Solubility Behavior in DEGME + Water Mixtures and Preparation of Nanosuspension Using Box–Behnken Design

IF5.5

2026-01-200

OAAI

Benzoxazole Derivatives as Potent FXR and PPARα Dual Agonists With Anti-Fibrotic and Metabolic Regulatory Effects

苯并噁唑衍生物作为强效FXR和PPARα双重激动剂，具有抗纤维化和代谢调节作用。

IF10.7

2025-10-260

OAAI

Physiologically based pharmacokinetic modeling for umbelliferone in rats and humans: impact of extrahepatic phase II metabolism and hepatic/gut first-pass extraction on oral bioavailability and systemic disposition

基于生理的药代动力学模型：伞形花内酯在啮齿动物和人体中的研究——肠外相II代谢以及肝/肠道首过提取对口服生物利用度和全身分布的影响

Journal of Pharmaceutical Investigation

IF5.1

2025-09-110

PRE

Design and Synthesis of Novel 6-(Substituted phenyl)-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d]thiazole Compounds as Tyrosinase Inhibitors: In Vitro and In Vivo Insights

IF4.6

2025-03-300

OAAI

Design, Synthesis, and Anti-Tyrosinase, Anti-Melanogenic, and Antioxidant Activities of Novel (Z)-3-Benzyl-5-Benzylidene-2-Thioxothiazolidin-4-One Analogs

IF4.6

2025-01-230

OAAI

Design, Synthesis, and Antioxidant and Anti-Tyrosinase Activities of (Z)-5-Benzylidene-2-(naphthalen-1-ylamino)thiazol-4(5H)-one Analogs: In Vitro and In Vivo Insights

IF4.6

2025-01-131

OAAI

Design, Synthesis, and Anti-Melanogenic Activity of 2-Mercaptomethylbenzo[d]imidazole Derivatives Serving as Tyrosinase Inhibitors: An In Silico, In Vitro, and In Vivo Exploration

IF6.6

2024-10-160

OAAI

Exploration of Compounds with 2-Phenylbenzo[d]oxazole Scaffold as Potential Skin-Lightening Agents through Inhibition of Melanin Biosynthesis and Tyrosinase Activity

IF4.6

2024-09-022

OAAI

Design, synthesis, and anti-melanogenic efficacy of 2-mercaptobenzoxazoles with nanomolar tyrosinase activity inhibition

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2024-08-012

PRE

Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases

IF4.6

2024-06-184

OAAI

In vitro and in vivo anti-pigmentation effects of 2-mercaptobenzimidazoles as nanomolar tyrosinase inhibitors on mammalian cells and zebrafish embryos: Preparation of pigment-free zebrafish embryos

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-02-017

PRE

Thiazol-4(5H)-one analogs as potent tyrosinase inhibitors: Synthesis, tyrosinase inhibition, antimelanogenic effect, antioxidant activity, and in silico docking simulation

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2024-01-019

PRE

Thiobarbiturate-Derived Compound MHY1025 Alleviates Renal Fibrosis by Modulating Oxidative Stress, Epithelial Inflammation, and Fibroblast Activation

IF6.6

2023-10-310

OAAI

Anti-Browning Effect of 2-Mercaptobenzo[d]imidazole Analogs with Antioxidant Activity on Freshly-Cut Apple Slices and Their Highly Potent Tyrosinase Inhibitory Activity

IF6.6

2023-09-296

OAAI

Ionically bridged dexamethasone sodium phosphate-zinc-PLGA nanocomplex in alginate microgel for the local treatment of ulcerative colitis

藻酸盐微凝胶中离子桥联地塞米松磷酸钠-锌-PLGA纳米复合物局部治疗溃疡性结肠炎

ARCHIVES OF PHARMACAL RESEARCH

IF7.5

2023-08-032

PRE